An Overview of the REGAL Trial and Anti-VEGF Therapies in Recurrent Glioblastoma
The ASCO Post,
Advertisement Annick Desjardins, MD, FRCPC "Despite its negative findings, the REGAL trial still teaches us a lot about the use…
Advertisement Annick Desjardins, MD, FRCPC "Despite its negative findings, the REGAL trial still teaches us a lot about the use…
As published in the Journal of Clinical Oncology by Batchelor and colleagues1 and reviewed in a recent issue of The ASCO Post (No…